LongBio Pharma (Suzhou) Co., Ltd. released an announcement on 10 September 2026 detailing the latest composition of its Board of Directors and the memberships of its three standing committees.

The Board now comprises three executive directors, four non-executive directors, and four independent non-executive directors: • Executive Directors – Dr. Liu Heng (Chairman), Dr. Sun Bill Nai-chau, and Mr. Xie Ming. • Non-executive Directors – Mr. Lin Jian, Ms. Gu Qin, Dr. Xue Di, and Mr. Xue Kailu. • Independent Non-executive Directors – Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun, and Mr. Zhou Guofang.

Committee leadership and participation are as follows: • Audit Committee – chaired by Mr. Siu Paul Yu Hay, with Mr. Ruan Tim and Mr. Yang Chun serving as members. • Remuneration Committee – chaired by Mr. Yang Chun; members include Mr. Siu Paul Yu Hay and Mr. Zhou Guofang. • Nomination Committee – chaired by Dr. Liu Heng, with Mr. Xie Ming, Mr. Lin Jian, Ms. Gu Qin, and Mr. Ruan Tim as members.

The announcement confirms that all committee assignments are effective immediately, aligning governance responsibilities with the current strategic and operational needs of LongBio Pharma.